SEC 13F Intelligence

Rock Springs Capital Management LP / AKRO

Rock Springs Capital Management LP’s Akero Therapeutics Inc Com Position

Does Rock Springs Capital Management LP own Akero Therapeutics Inc Com (AKRO)? Not currently — the last reported position was 626.5K shares worth $30M in Q3 2025; the fund’s latest 13F (Q1 2026) no longer reports it.

Position Value
$30M
Q3 2025
Shares
626.5K
% of Portfolio
+1.74%
Quarters Held
26
position exited

Position History AKRO

Reported value by quarter
Q2 ’19: $4MQ2 ’19Q3 ’19: $5MQ4 ’19: $5MQ1 ’20: $5MQ2 ’20: $6MQ2 ’20Q3 ’20: $13MQ4 ’20: $13MQ1 ’21: $15MQ2 ’21: $13MQ2 ’21Q3 ’21: $13MQ4 ’21: $12MQ1 ’22: $9MQ2 ’22: $6MQ2 ’22Q3 ’22: $47MQ4 ’22: $77MQ1 ’23: $56MQ2 ’23: $72MQ2 ’23Q3 ’23: $72MQ4 ’23: $25MQ1 ’24: $33MQ2 ’24: $25MQ2 ’24Q3 ’24: $27MQ4 ’24: $26MQ1 ’25: $27MQ2 ’25: $34MQ2 ’25Q3 ’25: $30Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q3 2025626.5K$30M+1.74%
Q2 2025640.5K$34M+2.13%
Q1 2025672.8K$27M+1.56%
Q4 2024946.5K$26M+1.00%
Q3 2024933.4K$27M+0.87%
Q2 20241.07M$25M+0.76%
Q1 20241.30M$33M+0.83%
Q4 20231.08M$25M+0.62%
Q3 20231.42M$72M+1.92%
Q2 20231.55M$72M+1.72%
Q1 20231.45M$56M+1.33%
Q4 20221.40M$77M+1.85%
Q3 20221.37M$47M+1.20%
Q2 2022679.5K$6M+0.19%
Q1 2022635.2K$9M+0.23%
Q4 2021587.1K$12M+0.29%
Q3 2021568.7K$13M+0.27%
Q2 2021528.6K$13M+0.26%
Q1 2021521.2K$15M+0.33%
Q4 2020515.4K$13M+0.28%
Q3 2020423.0K$13M+0.33%
Q2 2020243.0K$6M+0.17%
Q1 2020225.0K$5M+0.20%
Q4 2019225.0K$5M+0.16%
Q3 2019225.0K$5M+0.20%
Q2 2019225.0K$4M+0.16%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Rock Springs Capital Management LP’s full portfolio or all institutional holders of AKRO.